Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 295.15M | 302.54M | 292.48M | 286.24M | 241.37M | 227.71M |
Gross Profit | 65.97M | 71.41M | 66.11M | 66.81M | 58.33M | 48.07M |
EBITDA | 6.37M | 10.83M | 10.63M | 4.51M | 6.62M | -8.45M |
Net Income | 2.15M | 1.06M | 1.86M | -4.41M | -2.14M | -14.62M |
Balance Sheet | ||||||
Total Assets | 128.48M | 125.13M | 132.30M | 135.60M | 123.16M | 124.06M |
Cash, Cash Equivalents and Short-Term Investments | 55.38M | 60.87M | 47.03M | 34.98M | 29.80M | 38.44M |
Total Debt | 10.18M | 4.76M | 13.62M | 19.79M | 8.47M | 8.04M |
Total Liabilities | 29.71M | 25.20M | 33.43M | 38.60M | 21.75M | 20.51M |
Stockholders Equity | 98.77M | 99.93M | 98.87M | 97.01M | 101.42M | 103.55M |
Cash Flow | ||||||
Free Cash Flow | 28.46M | 21.58M | 19.01M | 10.74M | -4.79M | -12.48M |
Operating Cash Flow | 28.96M | 23.94M | 19.51M | 14.05M | -2.52M | -10.62M |
Investing Cash Flow | -2.70M | -2.78M | -419.00K | -3.70M | -1.78M | -1.85M |
Financing Cash Flow | -7.46M | -7.36M | -7.05M | -5.17M | -4.34M | -3.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | HK$380.80M | 8.03 | 9.10% | 4.02% | -4.97% | 111.21% | |
74 Outperform | HK$160.00M | 8.99 | 11.39% | 25.00% | -0.45% | 7.28% | |
67 Neutral | HK$132.47M | 124.44 | 1.07% | ― | 3.44% | -43.75% | |
66 Neutral | HK$594.09M | 29.49 | -1.12% | 12.57% | 1.30% | -85.43% | |
65 Neutral | $27.34B | 15.12 | -4.22% | 3.16% | 1.01% | 1.94% | |
44 Neutral | HK$227.21M | ― | -22.75% | ― | -4.08% | -12.24% | |
43 Neutral | HK$110.69M | ― | -3.55% | ― | -12.19% | -18.39% |